date,title,source
Oct-17-18,Axsome Therapeutics Receives FDA Orphan Drug Designation for AXS-12 for the Treatment of Narcolepsy,GlobeNewswire
Oct-18-18,Axsome Therapeutics Hosts R&D Day Today with Key Opinion Leaders Focusing on AXS-05 and Unmet Needs in Alzheimers Disease Agitation,GlobeNewswire
Nov-01-18,"Axsome Therapeutics to Report Third Quarter 2018 Financial Results on November 9, 2018",GlobeNewswire
Nov-09-18,Axsome: 3Q Earnings Snapshot,Associated Press
Nov-09-18,Axsome Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update,GlobeNewswire
Nov-14-18,Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder,GlobeNewswire
Nov-19-18,Axsome Therapeutics to Participate in 2018 Global Mizuho Investor Conference,GlobeNewswire
Nov-21-18,"Market Trends Toward New Normal in Wilhelmina International, Eyenovia, aTyr Pharma, Avinger, Viacom, and Axsome Therapeutics  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Nov-27-18,Axsome Therapeutics Expands Loan Agreement with Silicon Valley Bank Providing Additional Growth Capital Related to AXS-12 Product Candidate,GlobeNewswire
Dec-10-18,UPDATE: Axsome Therapeutics shares soar 24% premarket on positive trial of Alzheimer's therapy,MarketWatch
Dec-10-18,Axsome Therapeutics Announces Positive Outcome of Interim Analysis of ADVANCE-1 Phase 2/3 Trial of AXS-05 in Alzheimers Disease Agitation,GlobeNewswire
Dec-11-18,Today's Research Reports on Trending Tickers: Axsome Therapeutics and Avid Bioservices,ACCESSWIRE
Dec-18-18,Axsome Therapeutics to Present at Biotech Showcase 2019,GlobeNewswire
Dec-27-18,These 4 Healthcare Stocks Are Gaining Speed,ACCESSWIRE
Dec-27-18,Axsome Therapeutics Provides Year End 2018 Clinical Update,GlobeNewswire
Dec-31-18,These 4 Healthcare Stocks May Test December Highs,ACCESSWIRE
Dec-31-18,"New Research: Key Drivers of Growth for Trimble, Maxar Technologies, MagnaChip Semiconductor, Palo Alto Networks, AAR, and Axsome Therapeutics  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Jan-07-19,Axsome Therapeutics Raises $23.3 Million Under Existing ATM Facility,GlobeNewswire
Jan-07-19,AXSM News: Why Axsome Therapeutics Stock Is Skyrocketing Today,InvestorPlace
Jan-07-19,4 Healthcare Stocks Making Moves On Monday (1/7/19),ACCESSWIRE
Jan-07-19,Tiny Pharma Company Surges 160% on Positive Depression Drug Data,Bloomberg
Jan-07-19,Axsome's stock nearly triples on heavy volume after positive trial of depression treatment,MarketWatch
Jan-07-19,Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Major Depressive Disorder,GlobeNewswire
Jan-08-19,Here's Why Axsome Therapeutics Has Been a Rocket Ship This Week,Motley Fool
Jan-08-19,Axsome Therapeutics: Do Not Buy AXSM Stock After Its Monster Rally,InvestorPlace
Jan-08-19,Portfolios Making Up For Lost Time,Zacks
Jan-08-19,The Next Big Biotech Breakout,ACCESSWIRE
Jan-08-19,"The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase",Benzinga
Jan-09-19,Market Rally Extends to Biotech,ACCESSWIRE
Jan-09-19,This Stock Generated 25X Returns In Just Five Years: Could BTCY Be At The Same Crossroads?,ACCESSWIRE
Jan-10-19,Is This Why Axsome Therapeutics Is Losing Ground Again Today?,Motley Fool
Jan-15-19,3 Small-Cap Stocks With Big-Cap Potential,Motley Fool
